Rankings
▼
Calendar
TCRX Q3 2020 Earnings — TScan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TCRX
TScan Therapeutics, Inc.
$65M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$290,000
Gross Profit
-$6M
-1904.5% margin
Operating Income
-$7M
-2472.8% margin
Net Income
-$7M
-2472.4% margin
EPS (Diluted)
$-0.30
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$129,000
← FY 2020
All Quarters
Q4 2020 →